AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Semaglutide in South Africa
9 products registered with SAHPRA — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| WEGOVY 0,25 mg | 58/21.013/0223 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 11 Feb 2030 |
| WEGOVY 0,5 mg | 58/21.013/0224 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 11 Feb 2030 |
| WEGOVY 2,4 mg | 58/21.013/0227 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 11 Feb 2030 |
| WEGOVY 1 mg | 58/21.013/0225 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 11 Feb 2030 |
| WEGOVY 1,7 mg | 58/21.013/0226 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 11 Feb 2030 |
| RYBELSUS 14 mg | 56/21.13/0339 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 3 Sept 2029 |
| RYBELSUS 7 mg | 56/21.13/0338 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 3 Sept 2029 |
| RYBELSUS 3 mg | 56/21.13/0337 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 3 Sept 2029 |
| OZEMPIC | 53/21.13/0497 | Novo Nordisk (Pty) Ltd û (Rivonia) | active | 1 Jan 1900 |
Semaglutide — SAHPRA Registration Details
SAHPRA (South Africa) has 9 registered products containing Semaglutide, of which 9 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Semaglutide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.